Dr. Ashok Kumar Pandurangan | Cancer Drug | Distinguished Scientist Award
Associate Professor | B.S. Abdur Rahman Crescent Institute of Science and Technology | India
Dr. Ashok Kumar Pandurangan, Ph.D., is an accomplished Associate Professor at the School of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, India. His extensive research focuses on signal transduction in colon and breast cancer, ulcerative colitis and colitis-associated cancer, and natural product-based drug development and screening. With over a decade of international research experience, including postdoctoral fellowships at the University of Malaya, Universiti Putra Malaysia, and Children’s Hospital Oakland Research Institute (UCSF Benioff), Dr. Pandurangan has made significant contributions to cancer biology and therapeutic research. He has successfully led and collaborated on numerous national and international grants, advancing translational cancer studies. His exceptional academic record includes being listed among the Top 2% Scientists worldwide (2021–2024) by Stanford University, and he has received several prestigious awards such as the AGAR Research Excellence Award (2025) and the C.V. Raman Prize (2022) for outstanding research achievements. Dr. Pandurangan also serves as an Associate Editor for Frontiers in Cellular and Infection Microbiology and has edited multiple special issues and scientific books. His prolific scholarly output includes 100 publications, covering high-impact ISI and Scopus-indexed journals, 2,714 citations, and an h-index of 30, reflecting his substantial influence and enduring contributions to the fields of oncology, toxicology, and biomedical research
Profile: Scopus | ORCID | Google Scholar
Featured Publications
1. Pandurangan, A. K. (2013). Potential targets for prevention of colorectal cancer: A focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pacific Journal of Cancer Prevention, 14(4), 2201–2205. Cited by 239
2. Ashokkumar, P., & Sudhandiran, G. (2008). Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomedicine & Pharmacotherapy, 62(9), 590–597. Cited by 203
3. Ashok Kumar Pandurangan, Z. S., Mohebali, N., Mohd Esa, N., Chung, … (2015). Gallic acid suppresses inflammation in dextran sodium sulfate-induced colitis in mice: Possible mechanisms. International Immunopharmacology, 28(2), 1034–1043. Cited by 192
4. Ashok Kumar Pandurangan, N. M. E. (2014). Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: A review. Asian Pacific Journal of Cancer Prevention, 15(14), 5501–5508. Cited by 168
5. Degagné, E., Pandurangan, A., Bandhuvula, P., Kumar, A., Eltanawy, A., … (2014). Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. The Journal of Clinical Investigation, 124(12), 5368–5384. Cited by 164